Financials Acarix AB

Equities

ACARIX

SE0009268717

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm 11:07:13 2024-05-17 EDT 5-day change 1st Jan Change
0.3145 SEK +2.11% Intraday chart for Acarix AB +5.89% +65.70%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 65.91 167.1 219.7 71.81 139.9 249.1 - -
Enterprise Value (EV) 1 12.16 167.1 203.9 60.65 139.9 249.1 249.1 249.1
P/E ratio -0.7 x -2.32 x -2.36 x - -1.19 x - - -
Yield - - - - - - - -
Capitalization / Revenue 35.5 x - 58.4 x 12.3 x 22.4 x 4.59 x 1.41 x 0.97 x
EV / Revenue 35.5 x - 58.4 x 12.3 x 22.4 x 4.59 x 1.41 x 0.97 x
EV / EBITDA -1.56 x - -4.55 x -0.98 x -1.88 x -7.31 x 3.65 x 2.44 x
EV / FCF -1.48 x - -4.57 x -0.96 x -1.72 x -4.79 x -83 x -
FCF Yield -67.6% - -21.9% -104% -58.2% -20.9% -1.2% -
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 51,694 141,045 251,972 251,972 737,189 792,165 - -
Reference price 2 1.275 1.185 0.8720 0.2850 0.1898 0.3145 0.3145 0.3145
Announcement Date 2/20/20 4/20/21 2/17/22 2/16/23 2/15/24 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1.857 - 3.76 5.822 6.241 54.3 176.6 256.1
EBITDA 1 -42.33 - -48.32 -73.44 -74.46 -34.1 68.2 102
EBIT 1 -46.44 - -51.7 -76.48 -77.55 -39.8 50.2 84.2
Operating Margin -2,501.02% - -1,374.89% -1,313.55% -1,242.64% -73.3% 28.43% 32.88%
Earnings before Tax (EBT) 1 -46.43 - -51.73 -76.98 -77.84 -54 2 -
Net income 1 -46.46 -41.5 -51.73 -76.98 -77.84 -54 2 -
Net margin -2,501.83% - -1,375.82% -1,322.31% -1,247.22% -99.45% 1.13% -
EPS -1.830 -0.5100 -0.3700 - -0.1600 - - -
Free Cash Flow 1 -44.53 - -48.05 -75.02 -81.37 -52 -3 -
FCF margin -2,398.12% - -1,277.93% -1,288.56% -1,303.73% -95.76% -1.7% -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 2/20/20 4/20/21 2/17/22 2/16/23 2/15/24 - - -
1SEK in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q3 2022 Q4 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - 1.653 1.54 1.573 1.174 1.552 6.5 19 27.2
EBITDA 1 - - - -16.43 -21.28 -14.22 -13.8 -4.4 1
EBIT 1 - -22.61 - -17.23 -22 -14.93 -15 -6.2 -1
Operating Margin - -1,368% - -1,095.1% -1,873.76% -961.79% -230.77% -32.63% -3.68%
Earnings before Tax (EBT) - - - - - - - - -
Net income -21.11 - -22 - - - - - -
Net margin - - -1,428.83% - - - - - -
EPS -0.0800 - -0.0500 -0.0400 -0.0300 - - - -
Dividend per Share - - - - - - - - -
Announcement Date 11/16/22 2/16/23 8/31/23 11/9/23 2/15/24 5/14/24 - - -
1SEK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position 53.7 - 15.9 11.2 - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 -44.5 - -48.1 -75 -81.4 -52 -3 -
ROE (net income / shareholders' equity) -56.5% - -56.6% - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 - - - - - 1 2 -
Capex / Sales - - - - - 1.84% 1.13% -
Announcement Date 2/20/20 4/20/21 2/17/22 2/16/23 2/15/24 - - -
1SEK in Million
Estimates
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW